Uncategorized
-

NHS Prescription Charges and Medication Adherence in England
England still charges for most NHS prescriptions. Here is what the evidence says about cost, skipped doses in long-term conditions, and what you can do.
-

Period Poverty Is a Public Health Issue, and the Data on Its Health Consequences Is Harder to Ignore Than Ever
Period poverty health consequences in the UK go far beyond discomfort. Research links it to infection, school absence and significant mental health harm.
-

The Hidden Health Cost of the UK’s Housing Crisis: What Living in Cold, Damp Homes Is Actually Doing to People
Cold damp housing health UK: ONS data, NHS admissions and public health research reveal what poor insulation and fuel poverty are doing to children and
-

Alcohol and Cancer Risk: Why UK Public Health Messaging Has Consistently Undersold the Evidence
The link between alcohol and cancer is well-established, yet UK public awareness stays low. Here is what the evidence actually says about breast, bowel
-

Ozempic Face, Muscle Loss and Bone Density: The Side Effects of GLP-1 Drugs UK Prescribers Are Starting to Take Seriously
Beyond nausea: emerging clinical evidence on lean mass loss, bone density changes and facial volume loss with GLP-1 drugs, with reference to MHRA and NHS
-

Britain’s Ageing Workforce and Cognitive Health: What Employers and Individuals Are Getting Wrong About Brain Decline
Separating normal ageing from early dementia warning signs for cognitive decline ageing UK workers. What neuroscience and occupational health actually say.
-

Why Burnout and Depression Are Being Conflated in the UK, and Why the Distinction Actually Matters for Treatment
Clinical burnout and depression share symptoms but need different interventions. Here’s what UK occupational health data and NICE guidelines actually say.
-

Voice Assistants and Health Data: What Really Happens When You Ask Alexa About Your Symptoms
What UK data law and Ofcom say about the health questions you ask smart speakers, who holds your data and whether the answers are clinically safe.
-

GLP-1 Weight Loss Drugs on the NHS: Who Qualifies, What the Waiting Lists Look Like, and What the Evidence Actually Shows
A grounded look at NHS weight loss injections UK: semaglutide, tirzepatide, NICE eligibility criteria, real waiting times, and what the long-term trials
-

Ozempic Isn’t the Only Story: What the GLP-1 Drug Pipeline Means for Obesity Treatment in the UK
The GLP-1 drugs pipeline UK obesity treatment will look very different in five years. Here’s what oral candidates, combination therapies, and NICE
